Nova In Silico

novainsilico.com · Vienna, Austria

Nova In Silico is a biotechnology and computational modeling company that develops in silico (computer-based) models to support drug discovery, toxicology assessment, and biological research. It provides simulation tools and services that help pharmaceutical, biotech, and research organizations predict biological responses and optimize R&D decisions. The company generates revenue through software licensing, modeling projects, and related scientific consulting services.

  • MLOps & ML Platforms
Revenue
$1.5M
Employees
15
Founded
2018
Headquarters
Vienna, Austria

What 9 Arbolus experts think of Nova In Silico

NPS scores cluster in the 8–10 range, with 44% Promoters (NPS 10) and 56% Passives (NPS 7–8). Explicit renewal intent is high among those with significant spend, while lower spenders are less committed or in early-stage pilots. Implementation stages spread across less than one year to more than a year, with early-stage projects expressing cautious optimism. Key quantitative themes are enthusiastic satisfaction among decision-makers with options for growth as pilot stages mature.Overall Customer Sentiment: Positive

Who reviewed Nova In Silico

Total customers 9 6 current · 3 former
Reviews growth +5 in six months
Seniority of respondents
  • C-Suite 56% (5)
  • Director 33% (3)
  • Manager 11% (1)
Strategy Leader Director NPS 10 Will renew
Other Leader Manager NPS 10
Not specified Director NPS 8

Employer names and spend open once the report publishes.

Tell us when the Nova In Silico report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

33 Net Promoter Score, from 9 scored reviews
  • Promoters 3
  • Passives 6
  • Detractors 0

Cumulative NPS by month

+1 over 5 months
  • Jan 8
  • Feb 8
  • Mar 8
  • Apr 8
  • Jul 9

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 33 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 75%
  • Will renew 3
  • Undecided 1
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 50% 2 answers
  • Director 100% 2 answers
  • 9.3/10 Average score from customers who will renew
  • 8/10 Average score from undecided customers

For people who use Nova In Silico

Do you use Nova In Silico at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 9 customers of Nova In Silico have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.